CME sues CFTC over Kalshi's regulated Bitcoin perp launch

For crypto investors, CME's lawsuit against the CFTC matters because it could shape how far regulated Bitcoin derivatives can expand in the US. The case targets the agency's approval of KalshiEX's BTCPERP contract, a spot Bitcoin-linked perpetual product with no expiry that can support heavy leverage and forced liquidations during sharp price moves.

The CFTC approved the contract on May 29, one day after Kalshi filed it under Regulation 40.3. CME argues that decision put the product in the wrong category. According to the complaint, Kalshi's Bitcoin perpetual should be treated as a swap, not a futures contract, which would subject it to tighter Dodd-Frank rules.

Kalshi has already logged more than $5 billion in perpetual trading volume since launch. Shares of CME, Cboe, and ICE fell after the approval, suggesting investors saw the move as a threat to established exchanges. That makes the lawsuit more than a technical dispute over classification. It is also a fight over who gets to control the next phase of retail derivatives trading.

The challenge arrives as other groups push back too. The Futures Industry Association has urged the CFTC to set clearer rules for perpetual derivatives, while state officials and gaming groups are separately contesting how far federally regulated event markets should go.